About the
Award
The Tom Reeve Award for Outstanding Contributions to Cancer Care, offered annually by COSA, formally recognises a national leader who has made significant contributions to cancer care.
The successful nominee will be presented with a Gold Marryalyan at the 50th COSA Annual Scientific Meeting where they will be invited to deliver an address highlighting appropriate aspects of their area of professional interest.
Nominations have now closed for the 2023 Tom Reeve Award.
Award eligibility & criteria
To be eligible nominees must:
- have made significant contributions to cancer care through research clinical leadership and/or community service
- have made substantial contributions over a relatively long period of time
- be nominated by a COSA member and have support from a member of COSA Council
- be an Australia resident
Each nomination should include:
- an explanation of the nominee's work in the area of cancer control or research
- an evaluation of the accomplishments of the nominee
- letters of reference from two individuals from outside the nominees' institution (where applicable). These letters should contain a critical appraisal of the nominee's work
Nominations closed 5:00pm (AEST) 3 July 2023
Past Award recipients
Professor Thompson is a surgical oncologist who has spent a career focusing on the improvement of outcomes for patients diagnosed with cancer, and is recognised as an expert in the diagnosis and evidence-based management of melanoma.
As one of his nominators said, “There is no surgeon in Australia, with an interest in cancer and treating patients with malignant disease, with the profile held by John, nationally or internationally. I believe he would truly be a worthy recipient of this award and I sincerely believe that Tom Reeve would be delighted and very proud to see John receive it.”
Professor Thompson is Emeritus Professor of Melanoma and Surgical Oncology at The University of Sydney and Clinical Professor of Surgery at the University of Western Australia. He was the Director of the Sydney Melanoma Unit from 1998 and from 2007 was the Executive Director of Melanoma Institute Australia until the end of 2016. He has been author of over 950 peer-reviewed research articles in the scientific literature.
Professor Thompson is a past President of the International Sentinel Node Society, and was Chair of the Australian and New Zealand Melanoma Trials Group for 15 years. He is a member of the Melanoma Staging Committee of the American Joint Committee on Cancer, and chairs the Working Group that developed and regularly updates the Australian Clinical Practice Guidelines for the Management of Cutaneous Melanoma. He is an Honorary Fellow of the American Surgical Association and the American College of Surgeons, and is a Fellow of the Australian Academy of Health and Medical Sciences.
Professor Thompson is an outstanding and committed clinician, researcher, educator and mentor. He generously and liberally shares his experience and time with others and has acted as a teacher and mentor to successive generations of medical students, doctors in training, researchers, and senior clinicians. Many of his mentees over the past 20-30 years have themselves become accomplished international clinical and research leaders in the field of oncology, an objective testament to his tireless efforts to promote scientific achievement and clinical and translational research collaboration worldwide.
One of Professor Barton's nominators said: “As a pioneer of academic radiation oncology in Australia, Michael has made, and is still making, outstanding contributions to clinical care, in oncological research, and cancer services policy throughout his career. He would be a very worthy recipient of the Tom Reeve Award.” And the COSA Board agrees.
Professor Barton will be well known to the COSA community. He is a clinical academic specialist Radiation Oncology at Liverpool Hospital, Cancer Therapy Centre and Research Director of the Collaboration for Cancer Outcomes Research and Evaluation (CCORE), who has dedicated his lifetime’s work to the improvement and innovation in the field of radiation oncology and cancer care.
Michael’s greatest contribution to radiation oncology in Australia and internationally may be considered his work in providing the evidence on which to base health policy and advising governments on frameworks for cancer services and then evaluating the impact of those services. A pivotal study was the determination from evidence-based treatment guidelines of the percentage of cancer patients who should receive radiation therapy at some time in their treatment, which enabled planning of radiation services.
Throughout his career he has mentored, educated and researched all the while providing excellent, team-based clinical care. This has provided an environment that has brought on another generation of researchers and provided clinical care in the more resource-challenged areas of Greater Sydney.
Michael initiated the Basic Science in Oncology Course (BSOC) which has continued to grow and thrive since its inception in the early 1990’s. Countless clinicians from a range of oncology and palliative care backgrounds have benefited from this work. Most recently, he brought together the three cancer streams through the Translational Cancer Research Centres (TCRC) at the University of New South Wales into a cohesive team working closely together on research and translation of research into clinical care.
Michael has written 42 commissioned reports for a wide variety of agencies on the delivery plans for various health jurisdictions, including the International Atomic Energy Agency (IAEA), the World Health Organisation (WHO), and the Global Taskforce for the use of Radiotherapy for Cancer Control (GTFRCC), an international collaboration to advise and plan for expansion of radiotherapy facilities around the world to better cater for the cancer needs of every country, especially those countries with serious health service delivery deficits. He chaired the Australian guidelines for the management of Adult Gliomas.
In terms of individual research output, as Research Director of CCORE he has been awarded over $20M in peer-reviewed funding. He has published 200 original scientific papers in peer-reviewed journals, 43 published abstracts, 9 editorials, 2 books, 15 book chapters, 8 electronic publications, and has over 9048 citation and an h-index of 46.
And the list goes on!
Professor Barton OAM was presented with the Tom Reeve Award and delivered his oration, during the 2021 COSA ASM on Wednesday 17 November. The presentation and oration are available for ASM delegates to view as recorded content.
Professor, Translational Cancer Research, Director, Sansom Institute for Health Research
Dean, Research Strategy, Division of Health Sciences, University of South Australia
Executive Director, Victorian Comprehensive Cancer Centre
COSA President 1992-93
COSA President 2021-22
Medical Oncologist, North Sydney’s Mater Hospital
Director of the Patricia Ritchie Centre for Cancer Care and Research
Professor of Medical Oncology, University of Sydney
COSA President 2006-June 2006
Professor, Palliative and Supportive Services, Flinders University
Chief Cancer Officer, New South Wales
Chief Executive Officer, Cancer Institute of New South Wales
COSA President 2000-01
Professor, Palliative and Supportive Services, Flinders University
Chief Cancer Officer, New South Wales
Chief Executive Officer, Cancer Institute of New South Wales
Chief Executive Officer and Director of Research, Translational Research Institute
Chair of Lung Cancer Service, Peter MacCallum Cancer Centre
COSA President 2017-18
Director of the Medical Psychology Research Unit, The University of Sydney
Professor of Surgical Oncology, University of Newcastle
Director of Research, School of Nursing and Midwifery, Queensland University of Technology
Professor of Radiology, University or Melbourne
COSA President 1981-83
Professor of Cancer Medicine, The University of Sydney
COSA President 1994-95
Chief Executive Officer, Cancer Council Australia
Executive Officer, the Australian Cancer Network
About Emeritus Professor
Tom Reeve AC CBE
Professor Tom Reeve AC CBE is Emeritus Professor in Surgery of the University of Sydney where he graduated in 1947. After working in Sydney and Queensland, he trained in General and Thoracic Surgery at Albany Medical College, New York. In 1958, the American Board of Surgery certified Professor Reeve and he became a Fellow of the Royal Australasian College of Surgeons in 1967. He was Chairman of Surgery at The University of Sydney from 1982-1988 and chaired the Northern Sydney Health Area from 1988-1996.
On retirement, Professor Reeve became President of the Royal Australasian College of Surgeons and Executive Officer of the Australian Cancer Network. In this role, Professor Reeve was involved in the development of Clinical Guidelines for the Management of Early Breast Cancer, the first evidence-based cancer management guidelines produced in Australia.
Join Australia's leading oncology community & make an impact
Become a COSA memberTwitter
@COSAoncology
Follow
COSAoncology 2 days ago
COSA Groups reflect an interest in a tumour stream or specific cancer, age group, area, discipline or movement. When you join COSA, you can opt in to any number of Groups to reflect your specific interests in COSA. More: bit.ly/3emnboq
Read More >COSAoncology 3 days ago
RT by @cosaoncology: A great interview with #DickonHayne & @normanswan about @ANZUPtrials #BCGMM trial & @BelowTheBeltANZ study #SUBDUE1 @SpinnakerHRF #SouthMetropolitanHealthService @AstraZeneca @TrialsCentre @MSD_Aus #OmegaPharm @CancerAustralia @CancerAustralia @Prof_IanD abc.net.au/listen/program…
Read More >COSAoncology 3 days ago
Earlybird registration for the 2024 COSA CPG Education Course closes Friday 19 April 2024. Register today and save – not a COSA member? Join COSA and make further savings! bit.ly/3aNqaSr
Read More >COSAoncology 4 days ago
These steps show how to renew your COSA membership. Don't forget 2023 member rates are available for your 2024-25 membership until 30 April 2024! Start by logging in: bit.ly/4cI0nc3
Read More >COSAoncology 8 days ago
Make the most of your COSA membership savings! A discount applies if you’re a member of an Affiliated or Associated organisation. Plus - join before 30 April 2024 to get a saving on member rates before they increase for 2024. bit.ly/44ns3Oq
Read More >COSAoncology 10 days ago
Join COSA, the national multidisciplinary community for health care professionals working in cancer care. Get involved and make a difference in cancer care through collaboration, research, advocacy and education: bit.ly/3hXsDLm
Read More >COSAoncology 10 days ago
RT by @cosaoncology: Two great conferences come together... 🚨 Mark your 🗓️ - March 6-7 2025, Melbourne for the National 🇦🇺 @COSAoncology #Cancer #Survivorship Conference! 🗣️🦘🐨 #survonc #supponc
Read More >COSAoncology 10 days ago
RT by @cosaoncology: 🗓️ SAVE THE DATE FOR #TROGASM2025! Join us in Brisbane next March for the 2025 #TROGCancerResearch Annual Scientific Meeting. More details and speakers to be announced so stay tuned!
Read More >COSAoncology 12 days ago
RT by @cosaoncology: Looking forward to facilitating this important topic - survivorship care to support people with treatable but not curable cancer. Open to medical, nursing, allied health professionals, and people affected by cancer. Register here: cnsa.org.au/events/event/m… @UTS_Health @UTS_CST
Read More >COSAoncology 12 days ago
Join or renew your COSA membership before 30 April 2024 to get bonus months of membership and a saving! bit.ly/3hXsDLm
Read More >